Bharat Parenterals Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 598.2 million compared to INR 590.2 million a year ago. Revenue was INR 610.8 million compared to INR 625 million a year ago. Net income was INR 37.8 million compared to INR 28.5 million a year ago. Basic earnings per share from continuing operations was INR 6.45 compared to INR 4.94 a year ago. Diluted earnings per share from continuing operations was INR 6.45 compared to INR 4.94 a year ago.
For the nine months, sales was INR 1,895.4 million compared to INR 1,670.1 million a year ago. Revenue was INR 1,954.9 million compared to INR 1,784.4 million a year ago. Net income was INR 148.2 million compared to INR 139.5 million a year ago. Basic earnings per share from continuing operations was INR 25.56 compared to INR 24.16 a year ago. Diluted earnings per share from continuing operations was INR 25.56 compared to INR 24.16 a year ago.